Compare Affirm Holdings Inc (AFRM) vs AstraZeneca plc (AZN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Affirm Holdings Inc vs AstraZeneca plc — how do they compare? Affirm Holdings Inc trades at $77.07 (market cap $25.30B), while AstraZeneca plc trades at $158.1 (market cap $250.84B). The key difference: AstraZeneca plc is far larger — about 9.9× Affirm Holdings Inc's market cap, and AstraZeneca plc pays a 1.97% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.
| AFRM | AZN | |
|---|---|---|
Market Cap | $25.30B | $250.84B |
Sector | Financials | Health |
52-Week High | $92.18 | $209.48 |
52-Week Low | $42.53 | $147.06 |
Enterprise Value | $31.91B | $278.12B |
Dividend Yield | — | 1.97% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Affirm Holdings Inc
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →
